1. Introduction {#sec0005}
===============

Once esophagorespiratory fistulas (ERF) including esophagopulmonary fistulas (EPF) occur in patients with esophageal cancer with invasion to adjacent organs, saliva and food flow into the respiratory tract through the fistula and can cause fever, cough, and dyspnea; they frequently become refractory and cause severe illness \[[@bib0005], [@bib0030]\]. An esophageal covered expandable metallic stent (EMS) is a less-invasive treatment with a high rate of fistula closure \[[@bib0015], [@bib0030]\]. However, since a high incidence of complications such as perforation and bleeding was noted in a previous report, the indication for stent placement should be carefully considered \[[@bib0015], [@bib0020], [@bib0045]\].

An esophageal cancer patient with an EPF who underwent separation surgery with drainage tube-less (DRESS) esophagostomy and whose inflammation from the EPF could be effectively controlled, which facilitated the prompt administration of definitive chemoradiotherapy (CRT), is reported.

This case report has been reported in line with the SCARE criteria \[[@bib0070]\].

2. Presentation of case {#sec0010}
=======================

A 79-year-old man visited a clinic with a month-long history of dysphagia. Esophageal cancer at the middle thoracic esophagus was seen on endoscopic examination and esophagography ([Fig. 1](#fig0005){ref-type="fig"}a, b). On contrast-enhanced computed tomography (CT), the esophageal cancer seemed to invade the left main bronchus and the lower lobe of the right lung. There were metastases to regional lymph nodes, but there was no evidence of distant organ metastases.Fig. 1Endoscopic examination and Esophagography.a, Endoscopic examination shows esophageal cancer with stenosis.b, Esophagography (arrow) show esophageal cancer at the middle thoracic esophagus.Fig. 1

Three weeks later, the patient was transferred to our hospital and was examined in detail. Though fever and respiratory symptoms were not observed, positron emission tomography (PET)-CT and urgent CT detected a lung abscess in the lower lobe of the right lung that continued into the adjacent esophageal cancer, infiltrative shadows in the peripheral lung field, and a pleural effusion ([Fig. 2](#fig0010){ref-type="fig"}a, b). Blood tests showed an increased white blood cell (WBC) count of 9600/mm^2^ and a C-reactive protein of 13.43 mg/dL ([Table 1](#tbl0005){ref-type="table"}). Due to the presence of the EPF, the patient underwent emergency surgery that consisted of esophageal separation surgery and double bilateral esophagostomy and enterostomy. Antibiotic drug therapy for pneumonia and lung abscess achieved a favorable outcome ([Fig. 3](#fig0015){ref-type="fig"}a, b).Fig. 2Urgent computed tomography (CT) on the day of an esophagopulmonary fistula (EPF).a, CT shows a lung abscess (arrow) in the lower lobe of the right lung that continues into adjacent esophageal cancer.b, CT shows infiltrative shadows in the peripheral lung field and a pleural effusion.Fig. 2Fig. 3Computed tomography (CT) at postoperative 3 weeks.a, CT shows that the lung abscess have decreased compared to preoperative CT.b, CT shows that infiltrative shadows have disappeared.Fig. 3Table 1Laboratory data on the day of an esophagopulmonary fistula (EPF). Increased white blood cell (WBC) count of 9600/mm^2^ and C-reactive protein of 13.43 mg/dL are seen.Table 1Laboratory resultWhite blood cell count9600/mm^2^Red blood cell count3,380,000/mm^2^Hemoglobin10.3g/dlHematocrit29.7%Blood platelet count190,000/mm^2^Total protein5.55g/dlAlbumin2.02g/dlBlood urea nitrogen10.8mg/dlCreatinine0.67mg/dlTotal bilirubin1.2mg/dlAspartate aminotransferase25U/lAlanine aminotransferase15U/lLactate dehydrogenase122U/lAlkaline phosphatase151U/lNatrium125mmol/lKalium4.0mmol/lChlorine95mmol/lC-reactive protein13.43mg/dlProthrombin time (%)65.2%Activated partial thromboplastin time35.3s

Definitive CRT for the esophageal cancer was started from postoperative day 25. Radiotherapy was performed with a total dose of 46.8 Gy. Chemotherapy consisted of cisplatin (CDDP) and 5-fluorouracil (5-FU) therapy in 2 courses. Radiotherapy could not be completed because of sepsis due to aspiration pneumonia. The aspiration pneumonia improved with intensive treatment. At 90 days after surgery, the patient was discharged from the hospital. At six-month follow-up, the patient had achieved relapse-free survival and is currently symptom-free.

2.1. Separation surgery with DRESS esophagostomy {#sec0015}
------------------------------------------------

A bilateral neck diagonal incision was made. In the left side of the neck, the cervical esophagus was isolated and retracted by taping. On the right side neck, the cervical esophagus was isolated in the same way as on the left side and isolated by taping from the left side to the right side. The cervical esophagus was divided using a linear stapler ([Fig. 4](#fig0020){ref-type="fig"}a), and the distal esophageal stump was pulled out to the right supraclavicular region. To extend the region of the esophagostomy, the sternal head of sternocleidomastoid muscle was resected, and a skin flap was made around the region of the esophagostomy. The esophageal wall was fixed with skin all-round. In the same way, the proximal esophageal stump was pulled out to the left side neck for the esophagostomy (Figs. [4](#fig0020){ref-type="fig"}b and [5](#fig0025){ref-type="fig"}a ), and then enterostomy was performed by laparotomy.Fig. 4Scheme of the Separation surgery.a, The cervical esophagus is divided using a linear stapler.b, The proximal esophageal stump is pulled out to the left side neck, and the distal esophageal stump is pulled out to the right supraclavicular region.Fig. 4Fig. 5Drainage tube-less (DRESS) esophagostomy.a, Double bilateral esophagostomy of a 79-year-old man.b, Endoscopic investigations through the DRESS esophagostomy to evaluate esophageal cancer.Fig. 5

3. Discussion {#sec0020}
=============

The rate of ERFs in esophageal cancer patients with invasion to adjacent organs was reported to be approximately 5--10%, and it increased to 10--30% during or after CRT in the previous reports \[[@bib0005], [@bib0030]\]. An ERF invades the trachea, bronchus, or lung, and saliva and food flow into the respiratory tract continuously through the fistula, so that severe pneumonia or lung abscess can develop. The main symptoms of ERFs are fever, cough, and dyspnea. These patients often have stenosis of the esophagus and/or dysphagia, which cause malnutrition and a poor performance status. Therefore, pneumonia due to an ERF that progresses to sepsis is a life-threatening condition. Thus, ERFs should be diagnosed immediately, and rapid primary treatment is needed.

Alternatively, the treatment for the esophageal cancer in patients with an ERF should be considered concurrently with the treatment for pneumonia. Patients with an ERF have evidence of invasion into adjacent organs and a poor prognosis \[[@bib0010]\]. Definitive CRT for patients with invasion into adjacent organs produced a complete response in approximately 20--30% and 5-year survival of approximately 7--14% in the previous reports \[[@bib0010], [@bib0050], [@bib0055]\]. It was reported that the median survival period of the patients with ERFs who underwent palliative care ranged from 1 to 6 weeks due to their poor condition \[[@bib0005], [@bib0030]\]. The treatment strategy for an ERF is to first control the respiratory symptoms and inflammation, giving priority to immediate life-saving treatment. Second, CRT should be promptly performed in situations of controlled inflammation to improve the prognosis.

Various treatments for ERFs have been reported previously, such as esophageal covered EMS. Placement of a covered EMS in esophageal cancer patients with ERFs makes it possible to seal off the fistula with a high rate of success and contribute to less-invasive treatment \[[@bib0015], [@bib0030]\]. However, fistula regression was reported in 35% of patients \[[@bib0015], [@bib0020]\], and CRT during stent placement causes severe complications, such as bleeding or worsening pneumonia due to spread of the fistula; treatment-related death from CRT during stent placement was reported in 21% of patients \[[@bib0045]\]. Considering the high severe complication rate of this treatment, the indication for CRT during stent placement should be carefully considered after obtaining informed consent.

Esophagectomy with combined resection of invaded organs or bypass surgery is reported to prolong survival \[[@bib0025], [@bib0060], [@bib0065]\], but its high morbidity is also well known. Thus, postoperative complications might delay definitive CRT, and such surgeries do not necessarily benefit such patients.

Considering control of inflammation and initiation of CRT promptly as the primary option, less invasive treatments should be selected. Esophageal separation surgery provides good control of inflammation because of division of the respiratory tract from the alimentary tract certainly. Additionally, it is less invasive than esophageal bypass surgery in that the operative procedure involves only the cervical region, and no esophageal anastomosis is required, which allows prompt initiation of CRT. In the present case, there were no complications related to the esophagostomy, but complications such as stomal falling and subcutaneous leakage have been generally reported. The skin flap around the esophagostomy should be extensive, and the esophageal wall should be sutured with skin in a tensionless manner to prevent stomal falling.

In many cases of esophageal surgeries, an external esophagostomy is made with a drainage tube. An esophagostomy is placed in the right supraclavicular region or the left hypochondriac region, and indwelling drainage tubes were inserted into the esophagus to avoid creating a closed space at the oral and anal esophagus separated due to the esophageal cancer in the previous reports \[[@bib0010], [@bib0035], [@bib0040]\]. Therefore, drainage tubes sometimes cause trouble and affect the quality of life of patients after esophageal surgery. Meanwhile, esophagocutaneostomy can be managed easily without a drainage tube because of little fluid discharge. Therefore, our DRESS esophagostomy might improve patient's quality of life. Additionally, DRESS esophagostomy is useful for endoscopic investigations to evaluate esophageal cancer or the fistula ([Fig. 5](#fig0025){ref-type="fig"}b).

4. Conclusion {#sec0025}
=============

Separation surgery with a DRESS esophagostomy for an ERF is a promising method to improve patient's quality of life in advanced stage esophageal cancer with less invasiveness and with control of inflammation, facilitating subsequent definitive CRT.
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